The emerging therapy of the medication represents a exciting development in the care of type 2 diabetes. Unlike existing medications, tirzepatide affects two pathways – the GLP-1 hormone and the GIP hormone – https://tirzepatide-peptide200009.bleepblogs.com/42319098/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment